Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed the day trading at $2.67 down -1.48% from the previous closing price of $2.71. In other words, the price has decreased by -$1.48 from its previous closing price. On the day, 2.11 million shares were traded. BDTX stock price reached its highest trading level at $2.87 during the session, while it also had its lowest trading level at $2.605.
Ratios:
For a better understanding of BDTX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.13. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 152123024 and an Enterprise Value of 36290016. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 0.518 whereas that against EBITDA is 2.396.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.39, which has changed by 0.11715484 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -30.88%, while the 200-Day Moving Average is calculated to be -0.69%.
Shares Statistics:
Over the past 3-months, BDTX traded about 1.20M shares per day on average, while over the past 10 days, BDTX traded about 2261630 shares per day. A total of 56.94M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 21.46% of the company’s shares, while institutions hold 58.80% stake in the company. Shares short for BDTX as of 1763078400 were 6356283 with a Short Ratio of 5.28, compared to 1760486400 on 6198261. Therefore, it implies a Short% of Shares Outstanding of 6356283 and a Short% of Float of 16.009999999999998.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Black Diamond Therapeutics Inc (BDTX).The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.47 and $0.34 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.19 and -$0.83.
